Gadolinium-enhanced cardiac magnetic resonance imaging: administered dose in relationship to United States Food and Drug Administration (FDA) guidelines

Detalles Bibliográficos
Autores principales: Nacif, Marcelo, Arai, Andrew E, Lima, Joao A, Bluemke, David A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305027/
http://dx.doi.org/10.1186/1532-429X-14-S1-P46
_version_ 1782226993247420416
author Nacif, Marcelo
Arai, Andrew E
Lima, Joao A
Bluemke, David A
author_facet Nacif, Marcelo
Arai, Andrew E
Lima, Joao A
Bluemke, David A
author_sort Nacif, Marcelo
collection PubMed
description
format Online
Article
Text
id pubmed-3305027
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33050272012-03-16 Gadolinium-enhanced cardiac magnetic resonance imaging: administered dose in relationship to United States Food and Drug Administration (FDA) guidelines Nacif, Marcelo Arai, Andrew E Lima, Joao A Bluemke, David A J Cardiovasc Magn Reson Poster Presentation BioMed Central 2012-02-01 /pmc/articles/PMC3305027/ http://dx.doi.org/10.1186/1532-429X-14-S1-P46 Text en Copyright ©2012 Nacif et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Nacif, Marcelo
Arai, Andrew E
Lima, Joao A
Bluemke, David A
Gadolinium-enhanced cardiac magnetic resonance imaging: administered dose in relationship to United States Food and Drug Administration (FDA) guidelines
title Gadolinium-enhanced cardiac magnetic resonance imaging: administered dose in relationship to United States Food and Drug Administration (FDA) guidelines
title_full Gadolinium-enhanced cardiac magnetic resonance imaging: administered dose in relationship to United States Food and Drug Administration (FDA) guidelines
title_fullStr Gadolinium-enhanced cardiac magnetic resonance imaging: administered dose in relationship to United States Food and Drug Administration (FDA) guidelines
title_full_unstemmed Gadolinium-enhanced cardiac magnetic resonance imaging: administered dose in relationship to United States Food and Drug Administration (FDA) guidelines
title_short Gadolinium-enhanced cardiac magnetic resonance imaging: administered dose in relationship to United States Food and Drug Administration (FDA) guidelines
title_sort gadolinium-enhanced cardiac magnetic resonance imaging: administered dose in relationship to united states food and drug administration (fda) guidelines
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305027/
http://dx.doi.org/10.1186/1532-429X-14-S1-P46
work_keys_str_mv AT nacifmarcelo gadoliniumenhancedcardiacmagneticresonanceimagingadministereddoseinrelationshiptounitedstatesfoodanddrugadministrationfdaguidelines
AT araiandrewe gadoliniumenhancedcardiacmagneticresonanceimagingadministereddoseinrelationshiptounitedstatesfoodanddrugadministrationfdaguidelines
AT limajoaoa gadoliniumenhancedcardiacmagneticresonanceimagingadministereddoseinrelationshiptounitedstatesfoodanddrugadministrationfdaguidelines
AT bluemkedavida gadoliniumenhancedcardiacmagneticresonanceimagingadministereddoseinrelationshiptounitedstatesfoodanddrugadministrationfdaguidelines

Ejemplares similares